Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

North Carolina

Cancer surgery and procedure trials in North Carolina

79 cancer surgery and procedure studies are recruiting participants at sites in 46 cities across North Carolina as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every North Carolina city with a recruiting study

By research area: Lymphoma (27), Breast Cancer (16), Lung Cancer (15), Prostate Cancer (9), Melanoma (7), Pancreatic Cancer (5).

Durham (41), Chapel Hill (33), Winston-Salem (29), Charlotte (20), Clinton (14), Goldsboro (14), Jacksonville (14), Greenville (12), Pinehurst (12), Raleigh (10), Hendersonville (9), Asheville (8), Kernersville (7), Clemmons (6), Concord (6), Gastonia (6), Greensboro (6), Mooresville (6), Mount Airy (6), Cary (5), Hillsborough (5), Huntersville (5), Matthews (5), Monroe (5), Thomasville (5), Asheboro (4), Burlington (4), Reidsville (4), Albemarle (3), New Bern (3), Salisbury (3), Clyde (2), Forest City (2), High Point (2), North Wilkesboro (2), Shelby (2), Statesville (2), Stateville (2), Weaverville (2), Wilmington (2), Garner (1), Kinston (1), Lincolnton (1), Rocky Mount (1), Supply (1), Wilkesboro (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in North Carolina

Basic details from each study's public record (the 12 most recently updated of 79). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Clemmons · Winston-Salem
    Registry record
    NCT03606967 · updated
  2. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Asheboro · Burlington · Clinton · and 8 more U.S. locations
    Registry record
    NCT05564377 · updated
  3. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Chapel Hill · Durham
    Registry record
    NCT06995898 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in North Carolina on ClinicalTrials.gov.

Lung cancer: recently updated in North Carolina

  1. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Durham · Pinehurst · Raleigh
    Registry record
    NCT06498635 · updated
  2. Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Charlotte · Durham · Pinehurst · and 1 more U.S. location
    Registry record
    NCT07388524 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in North Carolina on ClinicalTrials.gov.

Prostate cancer: recently updated in North Carolina

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Chapel Hill · Hendersonville
    Registry record
    NCT03866382 · updated
  2. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Winston-Salem
    Registry record
    NCT05691465 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in North Carolina on ClinicalTrials.gov.

Melanoma: recently updated in North Carolina

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Clinton · Goldsboro · Jacksonville
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in North Carolina on ClinicalTrials.gov.

Lymphoma: recently updated in North Carolina

  1. Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Winston-Salem
    Registry record
    NCT03739814 · updated
  2. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

    • Phase 2
    • Up to 365 days
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Chapel Hill · Charlotte · Durham · and 2 more U.S. locations
    Registry record
    NCT06317662 · updated
  3. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Chapel Hill · Charlotte · Clemmons · and 8 more U.S. locations
    Registry record
    NCT06337318 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in North Carolina on ClinicalTrials.gov.

Pancreatic cancer: recently updated in North Carolina

  1. APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Clinton · Goldsboro · Jacksonville
    Registry record
    NCT04858334 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in North Carolina on ClinicalTrials.gov.

Ask about studies in North Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call